WZWei Zhu

Wei Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei Zhu has a total of 206 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Maternal Caffeine Exposure During Gestation on Neurobehavior, Glucose Metabolism and Circadian Rhythm in Offspring Rats

    by Minying Sun, Huanxin Pan, Guangyu Yang, Yan Zhang, Juntao Li, Xudong Li, Wei Zhu

    Caffeine intake can have numerous effects on neurological and cognitive impairments. However, its influences on offspring still need to be evaluated. This study aimed to investigate the effects of caffeine exposure during gestation on behavioral development, metabolic function, and circadian rhythms in offspring. A total of 96 Sprague–Dawley rats were included, with an equal number of males and females. After confirming pregnancy, the female rats were randomly divided into four groups on average and administered caffeine at three distinct doses (5, 20, and 80 mg/kg/day) or equivalent volumes of normal saline throughout the gestational period. The health status and weight gain of pregnant rats, as well as the litter size and body weight of offspring, were continuously monitored. Open field test, Morris water maze, intraperitoneal glucose tolerance tests (IPGTT) and intraperitoneal insulin tolerance tests (IPITTs) were performed. The expression levels of 7 circadian clock genes (Bmal1, Clock, Cry1, Cry2, Per1, Per2, and Rev-erbα) were quantified. This revealed a significant reduction in maternal weight gain in the 80 mg/kg caffeine group compared to controls. Although the birth weight of offspring was not significantly affected, the postnatal weight gain of offspring was slower in caffeine groups. Behavioral assessments demonstrated elevated spontaneous activity and increased anxiety-like behaviors in caffeine-exposed offspring. Metabolic evaluations indicated impaired glucose tolerance specifically in female offspring, though no significant alterations were observed in insulin sensitivity, spatial learning and memory performance. Maternal caffeine exposure during gestation also disrupted the rhythmicity of hepatic circadian clock gene expression in offspring rats. These findings suggest that gestational caffeine exposure exerts selective adverse effects on offspring development, behavior, glucose metabolism and circadian rhythm. Caffeine consumption during pregnancy necessitates careful consideration.

  • Developmental bisphenol A exposure alters adipose metabolism and lipid remodeling in female mouse offspring

    by Ting Zeng, Peiqi Huang, Hongting Pan, Congzheng Qi, Yan Wu, Ke Zhang, Yongqi Huang, Jinhui Li, Wei Zhu

  • Open Access

    Glucose and lipid metabolism indicators associate with metabolic syndrome risk prediction in adults with hypertension

    by Yingxin Guo, Lixuan Chen, Xinyi Ouyang, Minying Sun, Tao Lin, Xudong Li, Shanshan Wang, Qianxi Li, Tianpeng Wang, Zihan Yu, et al.

  • Open Access

    Co-Exposure to Bisphenol A and a High-Fat Diet Induces Insulin Resistance via Suppression of Insulin Signaling Molecule Expression and GLUT4 Translocation

    by Zeqi Lu, Min Cao, Jiaoxiang Zhang, Congzheng Qi, Bing Huang, Wenxue Li, Juntao Li, Guangyu Yang, Yan Zhang, Jinyin Wu, et al.

    While the adverse health effects of bisphenol A (BPA) or high-fat diet (HFD) exposure alone have been relatively well documented, the mechanisms underlying their combined impact on insulin resistance and type 2 diabetes remain poorly understood. In this study, we observed the effects of 90 days of treatment with BPA and an HFD on insulin resistance in mouse gastrocnemius muscle, as well as the expression of signaling molecules and proteins potentially associated with glucose transporter type 4 (GLUT4) translocation. Additionally, C2C12 myotubes were co-treated with BPA and palmitic acid (PA) to observe the effects on insulin signaling molecules, GLUT4 translocation, and insulin resistance. Specifically, in vitro cellular experiments further demonstrated that BPA and PA inhibited GLUT4 translocation from the nucleus to the cell membrane. Taken together, co-exposure to BPA and an HFD (or PA) treatment significantly altered the expression of insulin signaling molecules in both gastrocnemius muscle and C2C12 cells, suggesting a potential link to their impacts on insulin resistance and GLUT4 translocation.


  • 3,3′-Diindolylmethane ameliorate obesity-related skeletal muscle atrophy via regulating mitochondrial function

    by Yuquan Zhong, Siyuan Chen, Jingyun Pan, Ruomei Niu, Junqiang Du, Qiuxia Dong, Yanxi Liu, Yilu Yao, Yunfeng Lin, Heng Fang, et al.

  • Open Access

    Combination detection of IgG- and IgA-related autoantibodies for the early diagnosis of gastric cancer

    by Congcong Fu, Tao Wang, Xianzhu Zhou, Jianmin Fang, Yanlin Wang, Yuxin Wang, Xiaomao Yin, Wei Zhu, Hua Dong, Yiqi Du, et al.

    Background: Autoantibodies against tumor-associated antigens (TAAs) are promising noninvasive cancer biomarkers due to their specificity and stability. Gastric cancer (GC) diagnosis often requires invasive procedures, emphasizing the need for reliable blood-based biomarkers. Objective: This study assessed whether serum IgG and IgA autoantibodies, individually or combined, could serve as noninvasive biomarkers for gastric cancer. Experimental design: We analyzed 27 autoantibodies in serum from 265 healthy controls, 296 GC patients, and 195 gastritis patients using protein microarray. Autoantibody levels and the IgG/IgA ratio were calculated. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curves. Results: We identified 24 differentially expressed autoantibodies (DEAs) for IgA and 17 for IgG between GC patients and controls. In distinguishing GC from gastritis, 20 DEAs for IgA and 23 for IgG were significant. The IgG/IgA ratio of MIP1 beta had the highest diagnostic performance between atrophic gastritis and GC, while MMP7 was the most effective between chronic gastritis and GC. The gbm model with 14 autoantibodies had the highest Youden's index for GC versus controls, and a 13-autoantibody model performed best for GC versus all gastritis. Conclusions: Specific panels of autoantibodies could serve as noninvasive diagnostic tools for distinguishing GC from controls and gastritis.


  • Open Access

    Integrated Lipidomics and Network Pharmacology Reveal the AMPK-Mediated Therapeutic Mechanism of 3,3′-Diindolylmethane in Hepatic Lipid Metabolism

    by Xudong Li, Yunfeng Lin, Ruomei Niu, Siyuan Chen, Jingyun Pan, Yuquan Zhong, Junqiang Du, Qiuxia Dong, Hongfeng Zhang, Heng Fang, et al.

    Dysregulation of hepatic lipid metabolism constitutes a central mechanism in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD). 3,3′-Diindolylmethane (DIM), a bioactive compound abundant in dietary Brassica vegetables, exhibited protective effects on hepatocellular carcinoma and metabolic/inflammatory pathologies. Nevertheless, the effects of DIM on hepatic lipid metabolism and its underlying mechanisms remain unclear. Administration of DIM (50 mg/kg bw/day) prevented oxidative stress and hepatic lipid deposition in both high-fat diet (HFD)-fed wild-type (WT) and ob/ob mice. Lipidomics revealed that DIM diminished the lipogenesis and reshaped the hepatic lipid profile. Network pharmacology analysis identified the AMPK signaling pathway as the underlying mechanistic target for DIM in treating MASLD. In both HepG2 cells and mouse primary hepatocytes (MPH), DIM attenuated palmitic acid (PA)-induced cellular lipid accumulation, ROS generation, and reduction in oxygen consumption rate (OCR). These protective effects of DIM were diminished by co-treatment with Compound C (CC), a specific AMPK inhibitor. DIM administration enhanced AMPKα phosphorylation in vivo (WT/ob/ob mice) and in vitro (HepG2/MPH), concomitant with PPARα upregulation and SREBP1/ACC1 downregulation. CC abolished all DIM-induced molecular changes in vitro. Collectively, DIM alleviates hepatic lipid accumulation and oxidative stress in MASLD models through AMPK activation, subsequently modulating PPARα and SREBP1/ACC1 pathways.


  • Open Access

    Analysis of factors influencing the burden on family caregivers of disabled older adults in Guangzhou

    by Danrong Lin, Junbin Liao, Yanxi Liu, Yuquan Zhong, Jingyun Pan, Heng Fang, Yunfeng Lin, Yilu Yao, Jiewen Su, Bingjie Hu, et al.

    Objective: This study aims to investigate the current status of disability among older adults and analyze factors influencing the burden on their family caregivers in southern China.Methods: A cross-sectional survey was conducted among 334 pairs of disabled older adults (≥65 years) and their primary family caregivers across three districts in Guangzhou. Face-to-face interviews using standardized questionnaires assessed disability levels via the “Long-term Care Disability Level Assessment” scale and caregiver burden via the Zarit Burden Interview (ZBI) scale. For ordinal variables, the Kruskal-Wallis H test was applied for multi-group comparisons, while the Mann–Whitney U test was used for two-group analyses. Statistical significance was set at p < 0.05. Ordinal logistic regression identified factors associated with caregiver burden.Results: Among 334 disabled older adults in Guangzhou, the mean age was 82 years. Of these, 55.7% were married, 43.4% were male, 43.4% had an educational attainment of primary school or below. For the 334 family caregivers, 62.3% were female, 36.8% had completed high school or vocational education. The median years of caregiving experience was 5 years, with a median weekly caregiving time of 70 h. Caregiver burden distribution was as follows: 16.2% no burden, 41.0% mild burden, 28.7% moderate burden, and 14.1% severe burden. Statistically significant differences in caregiver burden were observed across the following variables (p < 0.05): disabled old adults’ activities of daily living (ADL), caregivers’ gender, child in school, physical disease, years of caregiving experience, weekly caregiving time, social interaction frequency, life satisfaction, and social support network size. Higher caregiver life satisfaction and elevated ADL scores in care recipients emerged as protective factors. Conversely, longer weekly caregiving hours and caregivers’ physical illness were identified as risk factors.Conclusion: This study identifies weekly caregiving time, caregivers’ physical disease, disabled older adults’ ADL capacity, and caregivers’ life satisfaction as critical determinants of burden severity in aging China, advocating multilevel interventions.


  • Open Access

    3,3′-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK Signaling

    by Jiewen Su, Heng Fang, Yunfeng Lin, Yilu Yao, Yanxi Liu, Yuquan Zhong, Xudong Li, Siyu Sun, Bing Huang, Guangyu Yang, et al.

    Background/Objectives: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic hepatic condition marked by lipid buildup, lipotoxicity, and inflammation. Prior research indicates that 3,3′-Diindolemethane (DIM), a natural indole-type phytochemical that is abundant in brassicaceae vegetables, has been reported to reduce body weight and improve lipid metabolism in mice subjected to a high-fat diet (HFD). The aryl hydrocarbon receptor (AhR), a nuclear receptor implicated in lipid metabolism and immune regulation, serves as a functional receptor for DIM. However, the underlying signaling pathways that regulate MAFLD remain elusive. Our objective is to ascertain the beneficial impact of DIM on MAFLD and the associated mechanisms. Methods: Hematoxylin and eosin staining, together with Oil Red O staining, were utilized to assess the pathological changes and lipid deposition in the liver. Biochemical analysis was employed to measure levels of triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), aspartate transaminase (AST), alanine transaminase (ALT), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). The cell survival rate of HepG2 cells treated with palmitic acid (PA) and DIM was assessed using the CCK-8 assay. Flow cytometry was employed to measure the fluorescence intensity emitted by lipid droplets within cells. Western blotting analysis was performed to assess AhR pathway and fatty acid transporter expression levels in hepatic tissue. Results: Our results showed that DIM significantly attenuated body weight gain and hepatic injury brought on by HFD, decreased lipid droplet accumulation in HepG2 cells, and effectively suppressed the phosphorylation of p38 MAPK and the protein expression levels of fatty acid transporters CD36 and FATP4. Conclusions: DIM reduced lipid accumulation by activating AhR and suppressing p38 MAPK phosphorylation, thereby inhibiting fatty acid transport and inflammatory responses. These findings suggest that DIM may represent a promising therapeutic candidate for MAFLD, warranting further exploration for clinical applications.


  • Open Access

    Development of an Anti-Zearalenone Nanobody Phage Display Library and Preparation of Specific Nanobodies

    by Ying Zeng, Yiying Hu, Ganying Chen, Qingqing Feng, Ruiting Wang, Zhilin Zhang, Jinxian Chen, Junbin Liao, Danrong Lin, Wei Zhu

    Zearalenone (ZEN), a toxic estrogenic mycotoxin in cereals, threatens human and animal health through reproductive, immune, and cytotoxic effects, necessitating sensitive detection methods. While nanobodies offer advantages over conventional antibodies for on-site ZEN detection, their application remains unexplored. This study aimed to develop an anti-ZEN nanobody derived from an anti-ZEN phage display nanobody library. An alpaca was immunized with a ZEN-bovine serum albumin (ZEN-BSA) antigen, achieving peak serum antibody titers (1:25,600) following four immunizations. A high-capacity phage display nanobody library (1.0 × 1011 plaque-forming units/mL) was constructed. Following four rounds of biopanning, an enrichment factor of 479 was achieved. Phage ELISA screening identified six phage display nanobodies with specific ZEN-binding activity, and multiple sequence alignment revealed four unique nanobody sequences. The selected phage display nanobody, designated phage-V44, was expressed and purified, and its presence was validated by SDS-PAGE and western blotting, which detected a single approximately 17 kDa band consistent with the expected nanobody size. We established a working curve for an indirect competitive enzyme-linked immunoassay (ELISA) for ZEN, which showed an IC50 value of 7.55 ng/mL. The specificity and affinity of the V44 were also verified. Collectively, the study successfully constructed an anti-ZEN phage display nanobody library, screened four specific ZEN-binding phage display nanobodies, and prepared the anti-ZEN nanobody V44. Thereby establishing a foundation for the nanobody’s future integration into rapid on-site detection methods for ZEN in both animal feed and human food products.